1887

Abstract

Summary

Employing different routes of immunization and different adjuvants, a large number of hybridomas were produced that secreted monoclonal antibodies (MAbs) against the large envelope glycoprotein (GP90) and the fusion glycoprotein (GP70) of respiratory syncytial virus (RSV). The antigenic specificity of the MAbs was established by immunoblot analysis and radioimmunoprecipitation. Three hybridomas secreting anti- GP90 MAbs were established from mice immunized by intraperitoneal injection of purified RSV in Freund’s complete adjuvant. MAbs from these hybridomas did not neutralize viral infectivity. Three other hybridomas established from mice immunized by intraperitoneal inoculation of purified RSV with produced anti- GP90 MAbs that neutralized the virus with or without complement. Similarly three other hybridomas established from mice immunized by infection with RSV via intranasal instillation of the virus produced anti-GP90 MAb that neutralized the virus in the presence and absence of complement. On the other hand, most anti-GP70 MAbs exhibited no neutralizing activity in the absence of complement, although many had low levels of neutralizing activity in the presence of complement, regardless of the type of immunization or the isotype of immunoglobulin. These observations suggest that there may be multiple antigenic sites on GP90, some of which involve a region of the molecule that functions in viral neutralization.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-8-2161
1987-08-01
2022-08-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/8/JV0680082161.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-8-2161&mimeType=html&fmt=ahah

References

  1. Anderson L. J., Hierholzer J. C., Stone Y. O., Tsou C., Fernie B. F. 1986; Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. Journal of Clinical Microbiology 23:475–478
    [Google Scholar]
  2. Belshe R. B., Van Voris L. P., Mufson M. A. 1982; Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. Journal of Infectious Diseases 145:311–319
    [Google Scholar]
  3. Fazekas De St.GROTH S., Scheidegger D. 1980; Production of monoclonal antibodies: strategy and tactics. Journal of Immunological Methods 35:1–21
    [Google Scholar]
  4. Fernie F. F., Cote P. J. Jr Gerin J. G. 1982; Classification of hybridomas to respiratory syncytial virus glycoproteins. Proceedings of the Society for Experimental Biology and Medicine 171:266–271
    [Google Scholar]
  5. Gruber C., Levine S. 1985; Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins. Journal of General Virology 66:417–432
    [Google Scholar]
  6. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
    [Google Scholar]
  7. Kim H. W., Arrobio J. O., Brandt C. D., Jeffries B. C., Pyle G., Reid J. L., Chanock R. M., Parrott R. H. 1973; Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. American Journal of Epidemiology 98:216–225
    [Google Scholar]
  8. Kingsbury D. W., Bratt M. A., Choppin P. W., Hanson R. P., Hosaka Y., Ter Meulen V., Norrby E., Plowright W., Rott R. 1978; Paramyxoviridae. Intervirology 10:137–152
    [Google Scholar]
  9. Srinivasappa J., Saegusa J., Prabhakar B. S., Gentry M. K., Buchmeier M. J., Wiktor T. J., Koprowski H., Oldstone M. B. A. 1986; Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. Journal of Virology 57:397–401
    [Google Scholar]
  10. Stott E. J., Bew M. J., Taylor G., Jebbett J., Collins A. P. 1984; The characterization and uses of monoclonal antibodies to respiratory syncytial virus. Developments in Biological Standardization 57:237–244
    [Google Scholar]
  11. Taniguchi K., Urasawa S., Urasawa T. 1985; Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. Journal of General Virology 66:1045–1053
    [Google Scholar]
  12. Ueba O. 1980; Purification and polypeptides of respiratory syncytial virus. Microbiology and Immunology 24:361–364
    [Google Scholar]
  13. Walsh E. E., Hruska J. 1983; Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion proteins. Journal of Virology 41:171–177
    [Google Scholar]
  14. Walsh E. E., Schlesinger J. J., Brandriss M. W. 1984; Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. Journal of General Virology 65:761–767
    [Google Scholar]
  15. Walsh E. E., Cote P. J., Fernie B. F., Schlesinger J. J., Brandriss M. W. 1986; Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. Journal of General Virology 67:505–513
    [Google Scholar]
  16. Wunner W. H., Pringle C. R. 1976; Respiratory syncytial virus proteins. Virology 73:228–243
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-8-2161
Loading
/content/journal/jgv/10.1099/0022-1317-68-8-2161
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error